Eelgrass (Zostera marina) restoration in Puget Sound: restoration tools, successes and challenges

Eelgrass (Zostera marina) is one of 25 Vital Signs to track the health of Puget Sound and restoration of this critical nearshore habitat is part of the overall regional recovery strategy. Eelgrass restoration will provide a multitude of benefits, ranging from habitat for species to ameliorating the effects of climate change. Since 2013, the Washington State Department of Natural Resources has led regional evaluation of potential eelgrass restoration sites and transplanting in Washington State. Through collaborations we have developed and tested strategies to enhance transplant success and restore natural processes. We developed an eelgrass transplant suitability model to identify potential restoration sites using key variables essential for seagrass production and long-term resilience in a changing environment. Eelgrass was planted at five sites for initial model verification with an additional 81 test sites planted between 2013 and 2017 to identify areas suitable for large scale restoration. Eelgrass test transplant results varied and 15 sites with the highest success were selected for large-scale transplantation. A comparison of standard transplant methods was performed and preliminary results suggest that proper method selection plays an important role in transplant success. Long-term monitoring is scheduled with an emphasis on the success of specific donor stocks, the recovery of donor sites, and the effect seagrass restoration has on water chemistry. The restoration process has endured challenges that ranged from permitting issues to anthropogenic and environmental stressors. However, issue specific solutions and adaptive management allowed the restoration process to progress and contribute valuable information towards strategies to recover this valuable habitat in the region

Eelgrass donor sites: potentially overlooked impacts of restoration in Puget Sound

Eelgrass (Zostera marina) is an important habitat in the Salish Sea and restoration efforts are being undertaken around the region to increase eelgrass abundance and resilience. Eelgrass restoration is typically performed by transplanting whole shoots or dispersing viable seeds collected from reproductive shoots to a site. Most of the restoration efforts in the Pacific Northwest utilize whole shoots harvested from donor meadows and transplanted into restoration areas, but little work has been done to look at the impacts of the harvest on the donor stock. In response to the lack of existing data for Puget Sound, Washington Department of Natural Resources and Pacific Northwest National Laboratory’s Marine Sciences Laboratory conducted a controlled harvest experiment in two regions of the Salish Sea at sites associated with ongoing restoration activities. These meadows were harvested under different pressure (i.e., different percentage of plants taken from 0 to 50%) using traditional harvesting techniques. The meadows were then monitored for two years for changes in density. The results indicated that the eelgrass meadows were surprisingly resilient to all levels of harvest under ideal conditions and in small harvest areas. Interpretation and implications of these results will be discussed, as well as potential considerations for choosing potential donor sites for future restoration efforts

Geological Storage of CO\u3csub\u3e2\u3c/sub\u3e in Sub-Seafloor Basalt: The CarbonSAFE Pre-Feasibility Study Offshore Washington State and British Columbia

The CarbonSAFE Cascadia project team is conducting a pre-feasibility study to evaluate technical and nontechnical aspects of collecting and storing 50 MMT of CO2 in a safe, ocean basalt reservoir offshore from Washington State and British Columbia. Sub-seafloor basalts are very common on Earth and enable CO2 mineralization as a long-term storage mechanism, permanently sequestering the carbon in solid rock form. Our project goals include the evaluation of this reservoir as an industrial-scale CO2 storage complex, developing potential source/transport scenarios, conducting laboratory and modeling studies to determine the potential capacity of the reservoir, and completing an assessment of economic, regulatory and project management risks. Potential scenarios include sources and transport options in the USA and in Canada. The overall project network consists of a coordination team of researchers from collaborating academic institutions, subcontractors, and external participants. Lessons learned from this study at the Cascadia Basin location may be transferrable elsewhere around the globe

Geological Storage of CO2 in Sub-Seafloor Basalt: The CarbonSAFE Pre-Feasibility Study Offshore Washington State and British Columbia

The CarbonSAFE Cascadia project team is conducting a pre-feasibility study to evaluate technical and nontechnical aspects of collecting and storing 50 MMT of CO2 in a safe, ocean basalt reservoir offshore from Washington State and British Columbia. Sub-seafloor basalts are very common on Earth and enable CO2 mineralization as a long-term storage mechanism, permanently sequestering the carbon in solid rock form. Our project goals include the evaluation of this reservoir as an industrial-scale CO2 storage complex, developing potential source/transport scenarios, conducting laboratory and modeling studies to determine the potential capacity of the reservoir, and completing an assessment of economic, regulatory and project management risks. Potential scenarios include sources and transport options in the USA and in Canada. The overall project network consists of a coordination team of researchers from collaborating academic institutions, subcontractors, and external participants. Lessons learned from this study at the Cascadia Basin location may be transferrable elsewhere around the globe

20% More Eelgrass in Puget Sound by 2020: Restoration Site Selection

As part of a larger program by the state of Washington to restore the Puget Sound ecosystem, we are engaged in a selection process to locate specific areas where eelgrass could be restored or enhanced to meet the goal of 20% more eelgrass by 2020, amounting to a ~4,000 ha increase in areal eelgrass coverage. Embedded in this goal is the establishment and development of meadows that are resilient to the effects of climate change and anthropogenic and natural disturbances. We hypothesize that: (1) many sites are recruitment limited; (2) eelgrass has been lost in some areas because of temporary disturbance; and (3) there may be broader stresses limiting eelgrass in subregions of Puget Sound. Our approach utilizes an understanding of eelgrass growth requirements coupled with hydrodynamic and water quality models, an eelgrass growth model, field observations, and test plantings. We are using these results along with spatial data and stressor information collected as part of regional assessments of nearshore ecosystem condition to identify restoration sites. We are also working with local governments to determine actions that could be taken to improve conditions for eelgrass within their jurisdictions to maximize the success and long-term viability of planted meadows. The models revealed differences in the predicted growth rate of eelgrass among regions. In general, northern Puget Sound and Strait of Juan de Fuca provided the best conditions, whereas Hood Canal and southern Puget Sound were relatively less suitable for eelgrass. Field visits were conducted at 23 sites where the eelgrass model predicted good growing conditions but where eelgrass does not presently exist based on available information. From among these sites we selected five sites for test planting. Test plantings, modeling and jurisdictional information will form the basis to develop strategies for larger recovery efforts

Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes.

OBJECTIVES: Venlafaxine (VLX), a serotonine-noradrenaline reuptake inhibitor, is one of the most commonly used antidepressant drugs in clinical practice for the treatment of major depressive disorder (MDD). Despite being more potent than its predecessors, similarly to them, the therapeutical effect of VLX is visible only 3-4 weeks after the beginning of treatment. Furthermore, recent papers show that antidepressants, including also VLX, enhance the motor recovery after stroke even in non depressed persons. In the present, transcriptomic-based study we looked for changes in gene expressions after a long-term VLX administration. METHODS: Osmotic minipumps were implanted subcutaneously into Dark Agouti rats providing a continuous (40 mg/kg/day) VLX delivery for three weeks. Frontal regions of the cerebral cortex were isolated and analyzed using Illumina bead arrays to detect genes showing significant chances in expression. Gene set enrichment analysis was performed to identify specific regulatory networks significantly affected by long term VLX treatment. RESULTS: Chronic VLX administration may have an effect on neurotransmitter release via the regulation of genes involved in vesicular exocytosis and receptor endocytosis (such as Kif proteins, Myo5a, Sv2b, Syn2 or Synj2). Simultaneously, VLX activated the expression of genes involved in neurotrophic signaling (Ntrk2, Ntrk3), glutamatergic transmission (Gria3, Grin2b and Grin2a), neuroplasticity (Camk2g/b, Cd47), synaptogenesis (Epha5a, Gad2) and cognitive processes (Clstn2). Interestingly, VLX increased the expression of genes involved in mitochondrial antioxidant activity (Bcl2 and Prdx1). Additionally, VLX administration also modulated genes related to insulin signaling pathway (Negr1, Ppp3r1, Slc2a4 and Enpp1), a mechanism that has recently been linked to neuroprotection, learning and memory. CONCLUSIONS: Our results strongly suggest that chronic VLX treatment improves functional reorganization and brain plasticity by influencing gene expression in regulatory networks of motor cortical areas. These results are consonant with the synaptic (network) hypothesis of depression and antidepressant-induced motor recovery after stroke

Multi-messenger observations of a binary neutron star merger

On 2017 August 17 a binary neutron star coalescence candidate (later designated GW170817) with merger time 12:41:04 UTC was observed through gravitational waves by the Advanced LIGO and Advanced Virgo detectors. The Fermi Gamma-ray Burst Monitor independently detected a gamma-ray burst (GRB 170817A) with a time delay of ~1.7 s with respect to the merger time. From the gravitational-wave signal, the source was initially localized to a sky region of 31 deg2 at a luminosity distance of 40+8-8 Mpc and with component masses consistent with neutron stars. The component masses were later measured to be in the range 0.86 to 2.26 Mo. An extensive observing campaign was launched across the electromagnetic spectrum leading to the discovery of a bright optical transient (SSS17a, now with the IAU identification of AT 2017gfo) in NGC 4993 (at ~40 Mpc) less than 11 hours after the merger by the One- Meter, Two Hemisphere (1M2H) team using the 1 m Swope Telescope. The optical transient was independently detected by multiple teams within an hour. Subsequent observations targeted the object and its environment. Early ultraviolet observations revealed a blue transient that faded within 48 hours. Optical and infrared observations showed a redward evolution over ~10 days. Following early non-detections, X-ray and radio emission were discovered at the transient’s position ~9 and ~16 days, respectively, after the merger. Both the X-ray and radio emission likely arise from a physical process that is distinct from the one that generates the UV/optical/near-infrared emission. No ultra-high-energy gamma-rays and no neutrino candidates consistent with the source were found in follow-up searches. These observations support the hypothesis that GW170817 was produced by the merger of two neutron stars in NGC4993 followed by a short gamma-ray burst (GRB 170817A) and a kilonova/macronova powered by the radioactive decay of r-process nuclei synthesized in the ejecta

Investigation of SARS-CoV-2 faecal shedding in the community: a prospective household cohort study (COVID-LIV) in the UK

Background SARS-CoV-2 is frequently shed in the stool of patients hospitalised with COVID-19. The extent of faecal shedding of SARS-CoV-2 among individuals in the community, and its potential to contribute to spread of disease, is unknown. Methods In this prospective, observational cohort study among households in Liverpool, UK, participants underwent weekly nasal/throat swabbing to detect SARS-CoV-2 virus, over a 12-week period from enrolment starting July 2020. Participants that tested positive for SARS-CoV-2 were asked to provide a stool sample three and 14 days later. In addition, in October and November 2020, during a period of high community transmission, stool sampling was undertaken to determine the prevalence of SARS-CoV-2 faecal shedding among all study participants. SARS-CoV-2 RNA was detected using Real-Time PCR. Results A total of 434 participants from 176 households were enrolled. Eighteen participants (4.2%: 95% confidence interval [CI] 2.5–6.5%) tested positive for SARS-CoV-2 virus on nasal/throat swabs and of these, 3/17 (18%: 95% CI 4–43%) had SARS-CoV-2 detected in stool. Two of three participants demonstrated ongoing faecal shedding of SARS-CoV-2, without gastrointestinal symptoms, after testing negative for SARS-CoV-2 in respiratory samples. Among 165/434 participants without SARS-CoV-2 infection and who took part in the prevalence study, none had SARS-CoV-2 in stool. There was no demonstrable household transmission of SARS-CoV-2 among households containing a participant with faecal shedding. Conclusions Faecal shedding of SARS-CoV-2 occurred among community participants with confirmed SARS-CoV-2 infection. However, during a period of high community transmission, faecal shedding of SARS-CoV-2 was not detected among participants without SARS-CoV-2 infection. It is unlikely that the faecal-oral route plays a significant role in household and community transmission of SARS-CoV-2